These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12814392)

  • 1. Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure.
    Zoccali C; Benedetto FA; Mallamaci F; Tripepi G; Cutrupi S; Parlongo S; Malatino LS; Bonanno G; Rapisarda F; Fatuzzo P; Seminara G; Nicocia G; Buemi M
    Eur J Clin Invest; 2003 Jul; 33(7):561-6. PubMed ID: 12814392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norepinephrine and concentric hypertrophy in patients with end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G; Parlongo S; Cutrupi S; Benedetto FA; Cataliotti A; Malatino LS;
    Hypertension; 2002 Jul; 40(1):41-6. PubMed ID: 12105136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G; Benedetto FA; Parlongo S; Cutrupi S; Bonanno G; Rapisarda F; Fatuzzo P; Seminara G; Cataliotti A; Malatino LS
    J Hypertens; 2003 Jul; 21(7):1355-62. PubMed ID: 12817184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent of left ventricular mass, circulating inflammatory markers rather than pressure load are associated with concentric left ventricular remodelling.
    Norton GR; Peterson VR; Robinson C; Norman G; Libhaber CD; Libhaber E; Gomes M; Sareli P; Woodiwiss AJ
    Int J Cardiol; 2019 Jan; 274():342-347. PubMed ID: 30287055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry.
    Wang H; Liu J; Yao XD; Li J; Yang Y; Cao TS; Yang B
    Nephrol Dial Transplant; 2012 Dec; 27(12):4422-9. PubMed ID: 22561582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum asymmetric dimethylarginine and left ventricular structure and function in patients with end‑stage renal disease treated with hemodialysis.
    Napora M; Graczykowska A; Próchniewska K; Zdrojewski Z; Całka A; Górny J; Stompór T
    Pol Arch Med Wewn; 2012; 122(5):226-34. PubMed ID: 22538734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction.
    Edelmann F; Tomaschitz A; Wachter R; Gelbrich G; Knoke M; Düngen HD; Pilz S; Binder L; Stahrenberg R; Schmidt A; März W; Pieske B
    Eur Heart J; 2012 Jan; 33(2):203-12. PubMed ID: 21856682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure.
    Woodiwiss AJ; Libhaber CD; Majane OH; Libhaber E; Maseko M; Norton GR
    Am J Hypertens; 2008 Oct; 21(10):1144-51. PubMed ID: 18756261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
    Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen and preclinical echocardiographic target organ damage: the strong heart study.
    Palmieri V; Celentano A; Roman MJ; de Simone G; Lewis MR; Best L; Lee ET; Robbins DC; Howard BV; Devereux RB
    Hypertension; 2001 Nov; 38(5):1068-74. PubMed ID: 11711499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute pulmonary edema in patients with reduced left ventricular ejection fraction is associated with concentric left ventricular geometry.
    Imanishi J; Kaihotsu K; Yoshikawa S; Nishimori M; Sone N; Honjo T; Iwahashi M
    Int J Cardiovasc Imaging; 2018 Feb; 34(2):185-192. PubMed ID: 28770454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.
    Wachtell K; Rokkedal J; Bella JN; Aalto T; Dahlöf B; Smith G; Roman MJ; Ibsen H; Aurigemma GP; Devereux RB
    Am J Cardiol; 2001 Jan; 87(1):54-60. PubMed ID: 11137834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of left ventricular geometry on regional systolic and diastolic function in patients with essential hypertension.
    Balci B; Yilmaz O
    Scand Cardiovasc J; 2002 Sep; 36(5):292-6. PubMed ID: 12470397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy.
    Taniguchi I; Kawai M; Date T; Yoshida S; Seki S; Taniguchi M; Shimizu M; Mochizuki S
    Circ J; 2006 Aug; 70(8):995-1000. PubMed ID: 16864931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of galectin-3 to left ventricular geometry and hypertrophy in chronic hemodialysis patients.
    Yilmaz H; Gurel OM; Celik HT; Bozkurt A; Yildirim ME; Bilgic I; Bilgic MA; Bavbek N; Akcay A
    Herz; 2015 Jun; 40(4):702-8. PubMed ID: 24924396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe obstructive sleep apnea elicits concentric left ventricular geometry.
    Cioffi G; Russo TE; Stefenelli C; Selmi A; Furlanello F; Cramariuc D; Gerdts E; de Simone G
    J Hypertens; 2010 May; 28(5):1074-82. PubMed ID: 20411620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Santucci A; Santucci C; Reboldi G; Porcellati C
    Am J Cardiol; 1996 Jul; 78(2):197-202. PubMed ID: 8712142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction.
    Milani RV; Drazner MH; Lavie CJ; Morin DP; Ventura HO
    Am J Cardiol; 2011 Oct; 108(7):992-6. PubMed ID: 21784383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc Levels in Left Ventricular Hypertrophy.
    Huang L; Teng T; Bian B; Yao W; Yu X; Wang Z; Xu Z; Sun Y
    Biol Trace Elem Res; 2017 Mar; 176(1):48-55. PubMed ID: 27452612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.